Gulam Rabbani Taban

Recent publications · Crossref

5 total works indexed

1. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

   · 2020 · cited 9,765x

2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,542x

3. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

   · 2018 · cited 2,108x

4. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

   · 2020 · cited 1,749x

5. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   · 2021 · cited 1,520x

via Crossref · CC0